NextMeds
NextMeds is a cash-pay telehealth platform offering compounded semaglutide and compounded tirzepatide on a flat monthly membership — one price bundling the medication (if prescribed), telehealth visits, a 1:1 care coach, and a licensed registered dietitian, with free shipping and no insurance.
- Semaglutide
- $129/mo (plus a separate fee, compounded)
- Tirzepatide
- $179/mo (plus a separate fee, compounded)
- Coverage
- All 50 states
- Brand-name
- Not confirmed
Weigh NextMeds against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.
Factor breakdown
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.
Strengths
- Flat monthly membership bundles the medication, telehealth visits, a 1:1 care coach and a licensed registered dietitian — one price, no hidden fees
- Same price every dose, no auto-renewal, cancel anytime; free shipping and no insurance needed (FSA eligible)
- Names a compounding pharmacy partner (Foothills Pharmacy) and states it services all 50 states
- Free, no-obligation online assessment before you pay anything
What to consider
- Shows a LegitScript 'approval' but links only a generic directory search, not a verifiable seal — we couldn't independently confirm it
- Promo-driven pricing with a countdown timer and 'price increases' urgency; the standing membership is $129 (sema) / $179 (tirz)
- A technology platform that coordinates care, not the medical provider; individual clinicians and a medical director aren't named on the site
- Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
- Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name
Bottom line — Grade C
Best for: Shoppers who want flat-price compounded semaglutide or tirzepatide bundled with a care coach and registered dietitian.
Site position #215 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.
Closest here
The rankings grading nearest NextMeds — the realistic shortlist.
Heros Health is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide for weight loss on a flat program price — $149 the first month, then $199/mo (or $165/mo on a 3-month plan) — with dose adjustments and clinician messaging included.
Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo).
Solo-physician DTC telemedicine clinic in Texas + Utah operated by Dr. Tran Le, MD (ABOM-board-certified obesity medicine, ABPM-certified addiction + occupational medicine, NPI 1194212258).
Coivas is an all-inclusive GLP-1 telehealth service operated by WellVi LLC (d/b/a Coivas) with prescriptions through Arora Health & Aesthetics, LLC.
Revel Health is a telehealth platform combining GLP-1 weight loss with longevity care — semaglutide and tirzepatide plus NAD+, sermorelin and peptide therapy — prescribed by board-certified physicians and compounded in USP 795/800-compliant facilities.
10rx advertises $297 semaglutide and $447 tirzepatide quarterly base plans. Named care and pharmacy partners improve the comparison, but pharmacy choice, full-term commitments and refund limits matter before paying.
The 19 rankings nearest this one
- #220 Oak63.2
- #221 WellMedr63.2
- #223 boostAGErx66.1
- #224 Ivologist66.1
- #225 Lumora66.1
- #226 MediRX66.1
- #227 NiceRx66.1
- #228 Rejuve Meds66.1
- #229 TeleHealth Med66.1
- #230 altRX66
- #231 Coby Health66
- #232 JumpstartMD66
- #233 PCOS Sisters66
- #234 Amble65.8
- #235 Medsol RX65.8
- #236 Neo Soma Healthcare65.8
- #237 Zeuss65.8
- #238 Alan Meds65.7
- #239 FMmeds65.7
Pricing/verification reflect NextMeds's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on NextMeds's site. Not medical advice; see our disclosure.